Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations

CA Arout, E Edens, IL Petrakis, M Sofuoglu - CNS drugs, 2015 - Springer
Opioid analgesics have become a cornerstone in the treatment of moderate to severe pain,
resulting in a steady rise of opioid prescriptions. Subsequently, there has been a striking …

[HTML][HTML] Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain

MJS Del Águila, M Schenk, KU Kern, T Drost… - Clinical Therapeutics, 2015 - Elsevier
Purpose Chronic pain is often challenging to address appropriately. Although patients with
severe chronic pain may respond to treatment with an opioid analgesic, opioids are often …

Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism

ED Kharasch, KJ Regina, J Blood, C Friedel - Anesthesiology, 2015 - pubs.asahq.org
Background Interindividual variability in methadone disposition remains unexplained, and
methadone accidental overdose in pain therapy is a significant public health problem …

Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study

MO Martel, PH Finan, AJ Dolman, S Subramanian… - Pain, 2015 - journals.lww.com
The primary purpose of this study was to examine the association between self-reports of
medication side effects and pain-related activity interference in patients with chronic pain …

Patient perspectives of acute pain management in the era of the opioid epidemic

RJ Smith, K Rhodes, B Paciotti, S Kelly… - Annals of emergency …, 2015 - Elsevier
Study objective To inform the development of interventions that could improve patient
engagement around the risks and benefits of alternative approaches to pain management in …

Long-term safety and efficacy of tapentadol extended release following up to 2 years of treatment in patients with moderate to severe, chronic pain: results of an open …

R Buynak, SA Rappaport, K Rod, P Arsenault… - Clinical Therapeutics, 2015 - Elsevier
Purpose Tapentadol extended release (ER) has demonstrated efficacy and safety for the
management of moderate to severe, chronic pain in adults. This study evaluated the long …

Pharmacokinetics of sublingual buprenorphine and naloxone in subjects with mild to severe hepatic impairment (Child-Pugh classes A, B, and C), in hepatitis C virus …

AF Nasser, C Heidbreder, Y Liu, PJ Fudala - Clinical pharmacokinetics, 2015 - Springer
Abstract Background and Objectives Suboxone® is a sublingual tablet of buprenorphine/
naloxone, approved for the treatment of opioid dependence. The objective of this study was …

Abuse-deterrent formulations: part 1–development of a formulation-based classification system

DJ Mastropietro, H Omidian - Expert opinion on drug metabolism & …, 2015 - Taylor & Francis
Introduction: Strategies have been implemented to decrease the large proportion of
individuals misusing abusable prescription medications. Abuse-deterrent formulations …

Pressure pain sensitivity in patients with suspected opioid-induced hyperalgesia

RA Wasserman, AL Hassett, SE Harte… - Regional Anesthesia & …, 2015 - rapm.bmj.com
Background and Objectives This study was designed to test whether a brief quantitative
sensory testing assessment could be used to detect hyperalgesia in patients with suspected …

An evaluation of discharge opioid prescribing practices in a burn population

L Wibbenmeyer, K Oltrogge, K Kluesner… - Journal of burn care …, 2015 - academic.oup.com
Opioids are the cornerstone of pain treatment in burn patients. Undertreatment of pain has
been associated with psychological sequela. However, prescription opioids have been …